These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 29369827)

  • 21. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
    Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
    Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
    J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk human papillomavirus and cervical lesions among women living with HIV/AIDS in Brazilian Amazon, Brazil.
    Silva Ld; Miranda A; Batalha R; Ferreira L; Santos M; Talhari S
    Braz J Infect Dis; 2015; 19(6):557-62. PubMed ID: 26260194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression and persistence of low-grade cervical squamous intraepithelial lesions in women living with human immunodeficiency virus.
    Zeier MD; Botha MH; van der Merwe FH; Eshun-Wilson I; van Schalkwyk M; la Grange M; Mason D; Louw M; Nachega JB
    J Low Genit Tract Dis; 2012 Jul; 16(3):243-50. PubMed ID: 22460273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HIV infection on atypical squamous cells of undetermined significance.
    Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
    Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
    Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
    AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.
    Yamada R; Sasagawa T; Kirumbi LW; Kingoro A; Karanja DK; Kiptoo M; Nakitare GW; Ichimura H; Inoue M
    J Med Virol; 2008 May; 80(5):847-55. PubMed ID: 18360898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.
    Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY
    Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV.
    McClymont E; Tan DH; Bondy S; Albert A; Coutlée F; Lee M; Walmsley S; Ogilvie G; Money D
    Int J STD AIDS; 2023 May; 34(6):402-407. PubMed ID: 36702811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
    Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
    J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
    Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
    Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
    BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
    Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
    Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.
    Cambou MC; Luz PM; Lake JE; Levi JE; Coutinho JR; de Andrade A; Heinke T; Derrico M; Veloso VG; Friedman RK; Grinsztejn B
    AIDS Patient Care STDS; 2015 Jan; 29(1):4-12. PubMed ID: 25361401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
    Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
    PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer.
    Ghartey J; Kovacs A; Burk RD; Stewart Massad L; Minkoff H; Xie X; Dʼsouza G; Xue X; Heather Watts D; Levine AM; Einstein MH; Colie C; Anastos K; Eltoum IE; Herold BC; Palefsky JM; Strickler HD
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):316-23. PubMed ID: 24694931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anal Cancer Precursor Lesions in HIV-Infected Persons: Tissue Human Papillomavirus Type Distribution and Impact on Treatment Response.
    Kobayashi T; Sigel K; Kalir T; MacLeod IJ; Liu Y; Gaisa M
    Dis Colon Rectum; 2019 May; 62(5):579-585. PubMed ID: 30570548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.